 Asian Scientist Magazine | Bristol-Myers Squibb: 52-Week High Recently Eclipsed (BMY) Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Bristol-Myers Squibb share prices have moved between a 52-week ... Bristol-Myers Squibb Booked a New High Bristol-Myers Squibb: Major Shareholders Supporting Shares in Q3 |
